Sanofi and GSK to seek authorization for COVID vaccine

Sanofi, GSK post 58% efficacy in omicron-affected COVID-19 vaccine trial, teeing up race to regulators

GSK/Sanofi Covid booster delayed by lack of uninfected people to test it on, GlaxoSmithKline

Sanofi eyes Covid-19 vaccine approval in early 2021; partners Translate Bio

Coronavirus Sanofi: French drug giant rows back after vaccine storm

Coronavirus vaccine uptake in EU Member States and UCPM Participating States – DG ECHO Daily Map, 02/06/2021 - Cyprus

COVID-19 vaccine Sanofi to seek permission for Phase 3 trial in India: Report

Stories making the news. - The Channel with Analysis

Sanofi and GSK to seek regulatory authorization for COVID-19 vaccine

New vaccine demonstrates strong protection against severe Covid-19 in clinical trials

Sanofi, GSK to seek US authorization for COVID-19 vaccine

Sanofi and GSK to seek authorization for COVID vaccine

COVID-19 Spring Vaccination Programme - spring terrace